Ventoux Biosciences Appoints Dr. Ken Lipson, PhD as Chief Scientific Officer
Ken Lipson, PhD – Chief Scientific Officer, Ventoux Biosciences A patient with debilitating and irreversible Dupuytren’s contracture in both hands Kurt Harrington – Founder and CEO, Ventoux Biosciences Ventoux Biosciences Elevates Leadership for Dupuytren’s Disease Therapies Dr. Lipson’s extensive experience in advancing drugs, from target identification through early clinical trials in fibrosis and oncology, is […]
The post Ventoux Biosciences Appoints Dr. Ken Lipson, PhD as Chief Scientific Officer first appeared on The Offspring Session.